Problems and pitfalls in evaluating studies for pacing in heart failure

Giornale Italiano di Cardiologia

Volumn 27, Issue 6, 1997, Pages 593-599

  Auricchio, Angelo ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Congestive heart failure; Pacemaker

Indexed keywords

CONGESTIVE HEART FAILURE; HEART PACING; HUMAN; PATHOPHYSIOLOGY; REVIEW; SURVIVAL;

CARDIAC PACING, ARTIFICIAL; HEART FAILURE, CONGESTIVE; HUMANS; SURVIVAL;

EID: 0031155241     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. HOCHLEITNER M, HORTNAGL H, FRIEDRICH L, et al: Long term efficacy of physiologic dual chamber pacing in the treatment of end-stage idiopathic dilated cardiomyopathy. Am J Cardiol 1992; 70: 1320-1325.
2. AURICCHIO A, SOMMARIVA L, SALO RW, et al: Improvement of cardiac function with severe congestive heart failure and coronary artery disease with shortened AV delay. Pacing Clin Electrophysiol 1993; 16: 2034-2043.
3. FOSTER AH, MCLAUGHLIN JS, FISHER ML: Improved hemodynamics with biventricular pacing (abstract). J Am Coll Cardiol 1994; 23 (Suppl A): 156.
4. BAKKER PJ, MEUBURG H, DE JONGE N, et al: Beneficial effects of biventricular pacing in congestive heart failure (abstract). Pacing Clin Electrophyisiol 1994; 17 (Part II): 820.
5. FELICIANO Z, FISHER ML, CORRETTI MC, GOTTUEB SS, GOLD MR: Acute hemodynam/c effect of AV delay in patients with congestive heart failure (abstract). J Am Coll Cardiol 1994; 23 (Suppl A): 349.
6. LINDE C, GAOLER F, EDNER M, NORDLANDER R, ROSENQUIST M: Is ODD pacing with short AV delay a beneficial treatment in patients with severe heart failure? (abstract). Pacing Clin Electrophysiol 1994; 17 (Part II): 744.
7. PAGANI M, FORZANI T, MONTANARI P, SEVESO G, ROMAND S: Effects of ODD pacing with short atrioventricular delay in dilated cardiomyopathy (abstract). Pacing Clin Electrophysiol 1994; 17 (Part II): 822.
8. GOLD MR, FELICIANO Z, GOTTLIEB SS, FISHER ML: Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: a randomized study. J Am Coll Cardiol 1995; 26: 967-973.
9. PêRALDO C, PUGUSI A, ROMANO S, et al: ODD pacing with short optimized AV delay in patients affected by dilated cardiomyopathy (abstract). Pacing Clin Electrophysiol 1996; 19: II-739.
10. THE CRITERIA COMMITTEE OF THE NEW YORK HEART ASSOCIATION: Diseases of the heart and blood vessels: nomenclature and criteria for diagnosis, 7th ed. Boston; Little Brown, 1973; 286-301.
11. GILBERT EM, PACKER M: The use of placebo controls. N Engl J Med 1995; 332: 61-65.
12. PACKER M: The placebo effect in heart failure. Am Heart J 1990; 120: 1579-1582.
13. CAPTOPRIL MULTICENTER RESEARCH GROUP: A placebo-controlled trial of captopril in refractory chronic con-gestive heart failure. J Am Coll Cardiol 1983; 2: 755-763.
14. CLELAND JGF, DARGIE HJ, BALL SG, et al: Effects of enalapri/ in heart failure: a double-blind study of effects in exercise performance, renal function, hormones, and metabolic state. Br Heart J 1985; 54: 305-312.
15. RODEHEFFER RJ, LfRMAN A, HEUBLEIN DM, BURNETT JC ÜR: Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc 1992; 67: 719-724.
16. ZILE MR, BLAUSTEIN AS, SHIMIZU G, GAASCH WH: Right ventricular pacing reduces the rate of left ventricular relaxation and filling. J Am Coll Cardiol 1987; 10: 702-709.
17. WISH M, FLETCHER RD, GOTTDIENER JS, COHEN AI: Importance of left atrial timing in the programming of dualchamber pacemakers. Am J Cardiol 1987; 60: 566-571.
18. CHIRIFE R, ORTEGA DF, SALAZAR AI: Nonphysiological left heart AV intervals as a result of ODD and AAI "physiological" pacing. Pacing Clin Electrophysiol 1991; 14: 1752-1756.
19. AURICCHIO A, SALO RW: Acute hemodynamic improvement by pacing in patients withsevere congestive heart failure. Pacing Clin Electrophysiol 1997; 20: 313-324.
20. SALO RW, AURICCHIO A, SALO MD, SOMMARIVA L, CHIARIEUO L: Modification of restrictive mitral filling patterns in congestive heart failure fay dual chamber pacing (abstract). Pacing Clin Electrophysiol 1995; 18: II-907.
21. COLUCCI WS, WYNNE J, HOLMAN BL, BRAUNWALD E: Long-term therapy of heart failure with prazosin: a randomized double-blind trial. Am J Cardiol 1980; 45: 337-344.
22. LEIER CVC, Huss PM, MAGORIEN RD, UNVERFETH DV: Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure. Circulation 1983; 67: 817-822.
23. DE MARIA AN, VISMARA LA, AUDITORE K, AMSTERDAM EA, ZEUS R, MASON DT: Effects of nitroglycerin on /eft ventricular cavity size and cardiac performance determined by ultrasound in man. Am J Med 1974; 57: 754-760.
24. FIRTH BG, DEHMER GJ, MARKHAM RV, WILLERSON JT, WILLIS LD: Assessment of vasodilator therapy in patients with severe congestive heart failure: /imitations of measurements of left ventricular ejection fraction and volumes. Am J Cardiol 1982; 50: 954-959.
25. ENLER R, RAY R, HIGGINS CB, et al: Clinical assessment and follow-up of functional capacity in patients with chronic congestive cardiomyopatfiy. Am J Cardiol 1982; 49: 1832-1837.
26. FRANCIOSA JA, PARK M, LEVINE TB: Lack of correlation between exercise capacity and indices of resting left ventricular performance in heart failure. Am J Cardiol 1981; 47: 33-39.
27. FRANCIOSA JA, JORDAN RA, WILEN MM, LEDDY CL: Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in controlled trial. Circulation 1984; 70: 63-68.
28. BRODIE BR, GROSSMAN M, MANN T, MCLAURIN LP: Effects of sodium nitroprusside on left ventricular diastolic pressure-volume relations. J Clin Invest 1977; 59: 59-68.
29. BRECKER SJ, XIAO HB, SPARROW J, GIBSON DG: Effect of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet 1992; 340: 1308-1312.
30. MASSIE B, BOURASSA M, Di BIANCO R, et al: Long term oral amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial. Circulation 1985; 71: 963-971.
31. COHN JN, JOHNSON G, ZIESCHE S, et al: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303-310.
32. WILSON JR, FERRARO N: Exercise intolerance in patients with chronic /eft heart failure: relation to oxygen transport and ventilatory abnormalities. Am J Cardiol 1983; 51: 1358-1363.
33. LEJEMTEL TH, MANCINI D, GUMBARDO D, CHADWICH B: Pitfalls and limitations of "maximal" oxygen uptake as an index of cardiovascular functional capacity in patients with chronic heart failure. Heart Failure 1985; 1: 112-124.
34. YEH MP, REED M, GARDNER M, et al: "Anaerobic threshold": problems of determination and validation. J Applied Physiol 1983; 55: 1178-1186.
35. LIPKIN DP, SACRIVEN AJ, CRAKE T, PooiE-WiisoN PA: Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J 1986; 292: 653-655.
36. McKAY CR, NANA M, KAWANISHI DT, et al: Importance of interna/ controls, statistical methods, and side effects in short-term trials of vasodilators: a study of hydralazine kinetics in patients with aortic régurgitation. Circulation 1985; 72: 865-872.
37. PACKER M, MEDINA N, YUSHAK M: Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure. Circulation 1985; 71: 761-766.
38. CORNYN JW, MASSIE BM, UNVERFERTH DV, LEIER CV: Hemodynamic changes after meals and placebo treatment in chronic congestive heart failure. Am J Cardiol 1986; 57: 238-241.
39. NISHIMURA RA, HAYES DL, HOLMES DR, et al: Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: an acute Doppler and catheterization hemodynamic study. J Am Coll Cardiol 1995; 25: 281-288.
40. LEIER CV, BINKLEY BF, RANDOLPH PH, UNVERFERTH DV: Chronic indoramin therapy in congestive heart failure: doubleblind, randomized, parallel placebo-controlled trials. J Am Coll Cardiol 1987; 9: 426-432.
41. MASSIE BM, KRAMER BL, TOPIC N: Lack of relationship between short term hemodynamic effect of captopril and subsequent clinical responses. Circulation 1984; 69: 1135-1141.
42. PACKER M, MEDINA N, YUSHAK M, MELLER J: Hemodynamic patterns for response during long-term captopril therapy for severe chronic heart failure. Circulation 1983; 869: 803-812.